Русский
Vitaprost Forte in the treament of patients with benign prostatic hyperplasia: pathogenetic basics and clinical results
DOI: https://dx.doi.org/10.18565/urology.2019.4.141-147
I.V. Kuz’min
Department of Urology of FGBOU VO Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia, Saint Petersburg, Russia
The review is dedicated to the history of creation, biological effects and clinical use of prostatic peptides. Pathogenetic basics of using peptide drugs in prostatic disease are discussed. The results of clinical trials of efficiency of drug Vitaprost Forte in patients with benign prostatic hyperplasia are shown.
About the Autors
Corresponding author: I.V. Kuz’min – MD, professor of the Department of Urology of FGBOU VO Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia, Saint Petersburg, Russia; e-mail: kuzminigor@mail.ru
Similar Articles
